CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE
One of the three clinical examples of hospital thrombolysis using Russian thrombolytic agent recombinant protein comprising an amino acid sequence of staphylokinase is described. The trial was held in Chelyabinsk Regional Vascular Centre of specialized medical care for patients with acute coronary s...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/56 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849228004522196992 |
|---|---|
| author | K. A. Kireev A. V. Krasnopeev S. V. Utkina |
| author_facet | K. A. Kireev A. V. Krasnopeev S. V. Utkina |
| author_sort | K. A. Kireev |
| collection | DOAJ |
| description | One of the three clinical examples of hospital thrombolysis using Russian thrombolytic agent recombinant protein comprising an amino acid sequence of staphylokinase is described. The trial was held in Chelyabinsk Regional Vascular Centre of specialized medical care for patients with acute coronary syndromes. Each of the three patients had similar reasons for systemic intravenous thrombolysis: hospitalization with ST-segment elevation myocardial infarction, unavailability of coronary interventions due to the X-ray operating room occupancy, high need for the reperfusion therapy in the setting of significant acute myocardial ischemia. In all the cases the pharmacologic reperfusion with recombinant protein comprising an amino acid sequence of staphylokinase was successful, hereafter percutaneous coronary interventions were performed. There were no complications registered. |
| format | Article |
| id | doaj-art-3e839572bc314cab8a7201605cdaf7b9 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2015-09-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-3e839572bc314cab8a7201605cdaf7b92025-08-23T10:00:16ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-01111404410.20996/1819-6446-2015-11-1-40-4455CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASEK. A. Kireev0A. V. Krasnopeev1S. V. Utkina2Road Clinical Hospital at Chelyabinsk station, JSC "Russian Railways", South Ural State Medical UniversityRoad Clinical Hospital at Chelyabinsk station, JSC "Russian Railways"Road Clinical Hospital at Chelyabinsk station, JSC "Russian Railways"One of the three clinical examples of hospital thrombolysis using Russian thrombolytic agent recombinant protein comprising an amino acid sequence of staphylokinase is described. The trial was held in Chelyabinsk Regional Vascular Centre of specialized medical care for patients with acute coronary syndromes. Each of the three patients had similar reasons for systemic intravenous thrombolysis: hospitalization with ST-segment elevation myocardial infarction, unavailability of coronary interventions due to the X-ray operating room occupancy, high need for the reperfusion therapy in the setting of significant acute myocardial ischemia. In all the cases the pharmacologic reperfusion with recombinant protein comprising an amino acid sequence of staphylokinase was successful, hereafter percutaneous coronary interventions were performed. There were no complications registered.https://www.rpcardio.online/jour/article/view/56thrombolytic therapypercutaneous coronary interventionacute myocardial infarctionrecombinant protein comprising an amino acid sequence of staphylokinase |
| spellingShingle | K. A. Kireev A. V. Krasnopeev S. V. Utkina CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE Рациональная фармакотерапия в кардиологии thrombolytic therapy percutaneous coronary intervention acute myocardial infarction recombinant protein comprising an amino acid sequence of staphylokinase |
| title | CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE |
| title_full | CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE |
| title_fullStr | CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE |
| title_full_unstemmed | CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE |
| title_short | CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE |
| title_sort | clinical case of russian thrombolytic agent fortelyzin r use in patients with acute coronary artery disease |
| topic | thrombolytic therapy percutaneous coronary intervention acute myocardial infarction recombinant protein comprising an amino acid sequence of staphylokinase |
| url | https://www.rpcardio.online/jour/article/view/56 |
| work_keys_str_mv | AT kakireev clinicalcaseofrussianthrombolyticagentfortelyzinuseinpatientswithacutecoronaryarterydisease AT avkrasnopeev clinicalcaseofrussianthrombolyticagentfortelyzinuseinpatientswithacutecoronaryarterydisease AT svutkina clinicalcaseofrussianthrombolyticagentfortelyzinuseinpatientswithacutecoronaryarterydisease |